All News about Astrazeneca Plc ADR
AstraZeneca advances scientific leadership in hematology at ASH 2023
November 29, 2023
From AstraZeneca
Via Business Wire
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
Via Benzinga
Exposures
Product Safety
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
November 09, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|